Axsome Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing selling pressure, which indicates risk of future bearish movement.

Axsome Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 71.79 Sell
20-day SMA: 75.21 Sell
50-day SMA: 80.42 Sell
200-day SMA: 74.94 Sell
8-day EMA: 72 Sell
20-day EMA: 74.25 Sell
50-day EMA: 77.35 Sell
200-day EMA: 75.09 Sell

Axsome Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.26 Sell
Relative Strength Index (14 RSI): 35.77 Sell
Chaikin Money Flow: -334726 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (70.69 - 77.95) Sell
Bollinger Bands (100): (69.29 - 88.25) Sell

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Axsome Therapeutics Stock

Is Axsome Therapeutics Stock a Buy?

AXSM Technical Analysis vs Fundamental Analysis

Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy or a Sell?

Axsome Therapeutics Stock Info

Market Cap:
Price in USD:
Share Volume:

Axsome Therapeutics 52-Week Range

52-Week High:
52-Week Low:
Axsome Therapeutics (AXSM) is a Sell

Axsome Therapeutics Share Price Forecast

Is Axsome Therapeutics Stock a Buy?

  • Axsome Therapeutics share price is 69.15 while AXSM 8-day exponential moving average is 72.00, which is a Sell signal.
  • The stock price of AXSM is 69.15 while Axsome Therapeutics 20-day EMA is 74.25, which makes it a Sell.
  • Axsome Therapeutics 50-day exponential moving average is 77.35 while AXSM share price is 69.15, making it a Sell technically.
  • AXSM stock price is 69.15 and Axsome Therapeutics 200-day simple moving average is 75.09, creating a Sell signal.

Fundamental Analysis of Axsome Therapeutics

Is Axsome Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $3.66 per share.

Technical Analysis of Axsome Therapeutics

Should I short Axsome Therapeutics stock?

* Axsome Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.